Editor's Picks
June 2025
in “
JEADV Clinical Practice
”
TLDR Scarring alopecia is linked to higher rates of vitamin D deficiency, metabolic issues, mental health problems, thyroid disease, and other health conditions.
The document presents three studies. The first study by Mora Hurtado et al. investigates the comorbidities associated with scarring alopecia, finding a higher prevalence of conditions like vitamin D deficiency, metabolic syndrome, and cardiovascular disease among patients compared to national averages, highlighting the need for better management and understanding of the disease. The second study by Andrade et al. reviews antifungal treatments for atopic dermatitis, concluding that there is weak evidence for their efficacy, thus not recommending their use. The third study by McKay et al. examines the use of IL-12/23 and IL-23 inhibitors in treating cutaneous Crohn's disease, reporting a 33% complete clearance rate in patients with anti-TNF refractory disease, suggesting these inhibitors as a safe and effective treatment option.
